Data regarding the occurrence of venous thromboembolic events (VTE), including acute
pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients …

Background: Coagulopathy associated with COVID-19 infection and venous
thromboembolism (VTE) have emerged as significant contributors to morbidity among …

Arterial thrombotic disease (atherosclerotic cardiovascular disease, CVD) and venous
thromboembolism (VTE)(comprising of deep vein thrombosis (DVT) and pulmonary …

Background Arterial and venous thrombosis are reported to be common in critically ill
COVID-19 patients. Method and results This is a national multicenter retrospective …

Background Patients with coronavirus disease 2019 (Covid-19) may experience venous
thrombosis while data regarding arterial thrombosis are sparse. Methods Prospective …

Methods We retrospectively reviewed the records of 4014 consecutive adult patients
admitted to a tertiary-level institution because of COVID-19 from March 2020 to March 2021 …

Objectives: This study aimed to investigate the clinical features of arterial thrombosis and
venous thromboembolism (VTE) in coronavirus disease 2019 (COVID-19). Methods: The …

2. Methods This study followed the Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) reporting guideline (Supplementary file 1). Data were obtained …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

Background Thrombosis and pulmonary embolism appear to be major causes of mortality in
hospitalized coronavirus disease 2019 (COVID-19) patients. However, few studies have …